An 8-year clinical study conducted by one of the companies that markets a blue scorpion venom cancer drug reported a 90% success rate for more than 8,000 patients with various forms and severity of the disease.
BOOM - and QNTA soon to be re-named to MedoLife Corp NOW OWNS THE PATENTS TO THE PUREST Blue Scorpion Venoms on PLANET EARTH and has BUILT THE LARGEST PRODUCTION FACILITY for same now in existence !!!